Emerge Bioscience Pte. Ltd., a subsidiary of Jianyou Co., Ltd., has received approval from the United States Food and Drug Administration (FDA) for its aspart insulin injection. This medication is intended to improve glycemic control in adult and pediatric patients with diabetes. The approval was communicated via a BLA approval letter. AI
RANK_REASON Product approval for a specific drug by a regulatory body.
- aspart insulin injection
- Emerge Bioscience Pte. Ltd.
- Jianyou Co., Ltd.
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
